RegentAtlantic Capital’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $229K | Hold |
3,015
| – | – | 0.01% | 610 |
|
|
2022
Q2 | $210K | Hold |
3,015
| – | – | 0.01% | 631 |
|
|
2022
Q1 | $250K | Hold |
3,015
| – | – | 0.01% | 612 |
|
|
2021
Q4 | $226K | Hold |
3,015
| – | – | 0.01% | 640 |
|
|
2021
Q3 | $350K | Sell |
3,015
-3
| -0.1% | -$348 | 0.01% | 515 |
|
|
2021
Q2 | $669K | Hold |
3,018
| – | – | 0.02% | 357 |
|
|
2021
Q1 | $399K | Sell |
3,018
-157
| -5% | -$20.8K | 0.01% | 424 |
|
|
2020
Q4 | $549K | Sell |
3,175
-1,040
| -25% | -$180K | 0.02% | 326 |
|
|
2020
Q3 | $469K | Buy |
4,215
+88
| +2% | +$9.79K | 0.02% | 330 |
|
|
2020
Q2 | $245K | Buy |
4,127
+15
| +0.4% | +$890 | 0.01% | 426 |
|
|
2020
Q1 | $277K | Sell |
4,112
-888
| -18% | -$59.8K | 0.02% | 341 |
|
|
2019
Q4 | $421K | Hold |
5,000
| – | – | 0.03% | 335 |
|
|
2019
Q3 | $374K | Hold |
5,000
| – | – | 0.02% | 344 |
|
|
2019
Q2 | $316K | Sell |
5,000
-112
| -2% | -$7.08K | 0.02% | 355 |
|
|
2019
Q1 | $246K | Sell |
5,112
-2,069
| -29% | -$99.6K | 0.02% | 389 |
|
|
2018
Q4 | $240K | Buy |
7,181
+112
| +2% | +$3.74K | 0.02% | 366 |
|
|
2018
Q3 | $370K | Hold |
7,069
| – | – | 0.03% | 324 |
|
|
2018
Q2 | $221K | Buy |
+7,069
| New | +$221K | 0.02% | 380 |
|
|
2018
Q1 | – | Sell |
-19,294
| Closed | -$390K | – | 420 |
|
|
2017
Q4 | $390K | Hold |
19,294
| – | – | 0.03% | 320 |
|
|
2017
Q3 | $383K | Hold |
19,294
| – | – | 0.03% | 311 |
|
|
2017
Q2 | $334K | Hold |
19,294
| – | – | 0.03% | 313 |
|
|
2017
Q1 | $156K | Hold |
19,294
| – | – | 0.01% | 390 |
|
|
2016
Q4 | $151K | Hold |
19,294
| – | – | 0.01% | 381 |
|
|
2016
Q3 | $165K | Hold |
19,294
| – | – | 0.02% | 375 |
|
|
2016
Q2 | $225K | Buy |
+19,294
| New | +$225K | 0.02% | 354 |
|